STOCK TITAN

BioLife Solutions Updates Earnings Call Information

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market, has provided updated dial-in information for their earnings call scheduled for today at 4:30pm ET. U.S. participants can dial 1-833-630-0431, while international callers should use 1-412-317-1808.

BioLife Solutions specializes in providing solutions that maintain the health and function of biological materials throughout the collection, development, manufacturing, and distribution processes, supporting the commercialization of new therapies in the CGT market.

BioLife Solutions (NASDAQ: BLFS), un'azienda leader nello sviluppo e fornitura di strumenti e servizi per il trattamento cellulare nel mercato della terapia cellulare e genica (CGT), ha fornito informazioni aggiornate per la chiamata sugli utili prevista per oggi alle 16:30 ET. I partecipanti negli Stati Uniti possono chiamare il numero 1-833-630-0431, mentre i chiamanti internazionali devono utilizzare il numero 1-412-317-1808.

BioLife Solutions si specializza nel fornire soluzioni che mantengono la salute e la funzionalità dei materiali biologici durante i processi di raccolta, sviluppo, produzione e distribuzione, supportando la commercializzazione di nuove terapie nel mercato CGT.

BioLife Solutions (NASDAQ: BLFS), un desarrollador y proveedor líder de herramientas y servicios para el procesamiento celular en el mercado de terapia celular y génica (CGT), ha proporcionado información actualizada para la llamada de resultados programada para hoy a las 4:30 pm ET. Los participantes en EE.UU. pueden marcar el 1-833-630-0431, mientras que los llamantes internacionales deben usar el 1-412-317-1808.

BioLife Solutions se especializa en ofrecer soluciones que mantienen la salud y función de los materiales biológicos durante los procesos de recolección, desarrollo, fabricación y distribución, apoyando la comercialización de nuevas terapias en el mercado CGT.

BioLife Solutions (NASDAQ: BLFS)는 세포 및 유전자 치료(CGT) 시장을 위한 세포 처리 도구 및 서비스를 개발하고 공급하는 선도 기업으로, 오늘 오후 4시 30분 ET에 예정된 실적 발표 전화 회의의 접속 정보를 업데이트했습니다. 미국 내 참가자는 1-833-630-0431로 전화할 수 있으며, 해외 참가자는 1-412-317-1808을 이용해야 합니다.

BioLife Solutions는 수집, 개발, 제조 및 유통 과정 전반에 걸쳐 생물학적 물질의 건강과 기능을 유지하는 솔루션을 제공하여 CGT 시장 내 새로운 치료법의 상용화를 지원하는 데 특화되어 있습니다.

BioLife Solutions (NASDAQ : BLFS), un développeur et fournisseur leader d'outils et services de traitement cellulaire pour le marché de la thérapie cellulaire et génique (CGT), a fourni des informations mises à jour pour sa conférence téléphonique sur les résultats prévue aujourd'hui à 16h30 ET. Les participants américains peuvent composer le 1-833-630-0431, tandis que les appelants internationaux doivent utiliser le 1-412-317-1808.

BioLife Solutions se spécialise dans la fourniture de solutions qui maintiennent la santé et la fonctionnalité des matériaux biologiques tout au long des processus de collecte, développement, fabrication et distribution, soutenant ainsi la commercialisation de nouvelles thérapies sur le marché CGT.

BioLife Solutions (NASDAQ: BLFS), ein führender Entwickler und Anbieter von Zellverarbeitungstools und -dienstleistungen für den Zell- und Gentherapiemarkt (CGT), hat aktualisierte Einwahlinformationen für seine Gewinnbekanntgabe, die heute um 16:30 Uhr ET stattfindet, bereitgestellt. US-Teilnehmer können die Nummer 1-833-630-0431 wählen, internationale Anrufer sollten 1-412-317-1808 verwenden.

BioLife Solutions ist darauf spezialisiert, Lösungen bereitzustellen, die die Gesundheit und Funktion biologischer Materialien während der Sammlung, Entwicklung, Herstellung und Verteilung erhalten und so die Kommerzialisierung neuer Therapien im CGT-Markt unterstützen.

Positive
  • None.
Negative
  • None.

BOTHELL, Wash., May 8, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, is announcing corrected call-in numbers for their Earnings Call this afternoon at 4:30pm ET. If you are joining, please use 1-833-630-0431 if calling from the United States or 1-412-317-1808 if dialing internationally.

About BioLife Solutions

BioLife is a leading developer and supplier of cell processing tools and services for the CGT market. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. For more information, please visit www.biolifesolutions.com, and follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company

Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com 

Investors

Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-updates-earnings-call-information-302450601.html

SOURCE BioLife Solutions, Inc.

FAQ

When is BioLife Solutions (BLFS) Q1 2025 earnings call?

BioLife Solutions' earnings call is scheduled for May 8, 2025, at 4:30pm ET.

What are the dial-in numbers for BioLife Solutions' earnings call?

For U.S. callers: 1-833-630-0431; for international callers: 1-412-317-1808.

What does BioLife Solutions (BLFS) do?

BioLife Solutions is a developer and supplier of cell processing tools and services for the cell and gene therapy market, providing solutions for maintaining biological materials during collection, development, manufacturing, and distribution.

Who is the CFO of BioLife Solutions (BLFS)?

Troy Wichterman serves as the Chief Financial Officer of BioLife Solutions.
Biolife Solutions Inc

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Stock Data

1.17B
46.18M
1.85%
101.8%
7.24%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
BOTHELL